AHL
TMCI icon

Abel Hall LLC’s Treace Medical Concepts TMCI Stock Holding History

Abel Hall LLC’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$148K Sell
37,219
-1,413
-4% -$3.88K 0.03% 792
2026
Q1 		$51.8K Buy
+38,632
New +$77K 0.01% 741

Other funds holding TMCI

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return
TFA
TrustWell Financial Advisors Jacksonville, Florida $118M AUM
TCOT
Trust Company of Toledo Holland, Ohio $1.2B AUM 33.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
PWA
Physician Wealth Advisors Midvale, Utah $837M AUM 26% 1-Year Est. Return
HI
Hoey Investments Coatesville, Pennsylvania $774M AUM 27.34% 1-Year Est. Return

Abel Hall LLC's TMCI Position: Q2 2026 in Review

Abel Hall LLC reduced its Treace Medical Concepts (TMCI) stake by 3.7% in Q2 2026, selling an estimated $3.88K and leaving 37,219 shares worth $148K. The position accounts for 0.03% of the portfolio, ranked #792.

Abel Hall LLC first reported a position in TMCI in Q1 2026 and has held it in 2 quarters since. 17 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • Abel Hall LLC held 37,219 shares of Treace Medical Concepts worth $148K as of Q2 2026.
  • Abel Hall LLC sold 1,413 Treace Medical Concepts shares in Q2 2026, an estimated $3.88K.
  • Treace Medical Concepts made up 0.03% of Abel Hall LLC's portfolio in Q2 2026, its #792 holding.
  • Abel Hall LLC first reported a position in Treace Medical Concepts in Q1 2026 and has held it in 2 quarters since.
  • 17 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on Abel Hall LLC's 13F filing for Q2 2026, filed 24 Jul 2026.